{
  "id": 9342514,
  "title": "FDA advisers are voting on Grail's multicancer blood test as Medicare coverage hangs in the balance",
  "url": "https://urgent.news/2026/09/23/fda-advisers-are-voting-on-grails-multicancer-blood-test-as-medicare",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-23T13:30:33.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/fda-advisers-grail-galleri-multicancer-blood-test-092326"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Molecular and Clinical Genetics Panel is weighing the Galleri test's clinical evidence today; Medicare coverage could follow FDA approval",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 4,
    "also_reported_by": [
      {
        "outlet": "NPR",
        "title": "Will FDA advisers recommend a multi-cancer blood test for approval? They'll vote",
        "url": "https://urgent.news/2026/09/23/will-fda-advisers-recommend-a-multi-cancer-blood-test-for-approval",
        "published": "2026-09-23T10:00:00.000Z"
      },
      {
        "outlet": "MarketWatch Top",
        "title": "FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.",
        "url": "https://urgent.news/2026/09/23/fda-advisers-are-reviewing-a-multicancer-detection-test-medicare",
        "published": "2026-09-23T12:39:00.000Z"
      },
      {
        "outlet": "Winnipeg Free Press",
        "title": "Grail’s cancer blood test faces high-stakes FDA review",
        "url": "https://urgent.news/2026/09/23/grails-cancer-blood-test-faces-high-stakes-fda-review",
        "published": "2026-09-23T13:23:13.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}